Celyad Oncology SA (CYAD) Earnings History & Surprises

NASDAQ:CYADUS1512052002

Current stock price

0.47 USD
-0.06 (-11.1%)
Last:

CYAD Earnings overview

Past quarterly earnings results for Celyad Oncology SA (CYAD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Aug 3, 2023

Last Reported

Most Recent
Release Date
May 11, 2023
Period
Q4 / 2022
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2022 - - - -
Q2 2022 -0.65 - - - -
Q4 2021 -1.76 - - - -
Q2 2021 - - - -100.00%
Q4 2020 - - - -
Q2 2020 - - 5K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

CYAD Revenue Q2Q GrowthCYAD Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Celyad Oncology SA / CYAD Earnings FAQ

When did Celyad Oncology SA (CYAD) report earnings last quarter?

Celyad Oncology SA (CYAD) last reported earnings on 5/11/2023.

Did CYAD stock beat earnings estimates in the most recent quarter?

Celyad Oncology SA (CYAD) missed EPS estimates and missed revenue estimates in the most recent quarter.